Noida Airport Joins 10 New Gateways Proposed for Regulated Drug Imports, Government Announces
The Indian government has proposed designating Noida airport alongside nine other airports as official gateways for regulated drug imports, aiming to modernize pharmaceutical supply chains. The initiative signals a strategic shift in national import infrastructure amid rising demand for life-saving medicines.
- Noida airport is among ten new airports proposed as gateways for regulated drug imports by the Ministry of Commerce.
- The initiative targets pharmaceutical supply chain efficiency, aiming to reduce congestion at existing import points.
- Stakeholders emphasize that infrastructure upgrades must accompany the expansion to ensure security and compliance.
In a significant regulatory development, the Ministry of Commerce and Industry has proposed adding Noida airport to a list of ten new designated gateways for controlled drug imports, officials confirmed on Friday. The move aims to decongest existing entry points and streamline the flow of pharmaceuticals into the domestic market.
The proposal emerges from a broader review of India's pharmaceutical logistics infrastructure, which has long relied on a limited network of notified airports for import clearance. With domestic pharma demand surging post-pandemic and global supply chains under strain, expanding the gateway network is intended to enhance efficiency while maintaining rigorous customs and security oversight.
A senior official from the Directorate General of Foreign Trade, speaking on condition of anonymity, said the plan reflects a strategic alignment with global pharma trade patterns. The Federation of Indian Pharmaceuticals has welcomed the step, noting it could significantly lower transit times for life-saving medicines. Customs bodies, however, cautioned that expanded gateways must be matched with upgraded inspection infrastructure to prevent illicit inflows.
